94 related articles for article (PubMed ID: 18419622)
41. [The value of radiotherapy in the treatment of aggressive and localised gastric lymphomas].
Ben Salah H; Ghorbel L; Krichen MS; Bellaaj H; Elloumi M; Frikha M; Daoud J
Cancer Radiother; 2009 Jan; 13(1):11-6. PubMed ID: 19091618
[TBL] [Abstract][Full Text] [Related]
42. Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.
Schaefer KL; Eisenacher M; Braun Y; Brachwitz K; Wai DH; Dirksen U; Lanvers-Kaminsky C; Juergens H; Herrero D; Stegmaier S; Koscielniak E; Eggert A; Nathrath M; Gosheger G; Schneider DT; Bury C; Diallo-Danebrock R; Ottaviano L; Gabbert HE; Poremba C
Eur J Cancer; 2008 Mar; 44(5):699-709. PubMed ID: 18294840
[TBL] [Abstract][Full Text] [Related]
43. Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
Oudejans JJ; van Wieringen WN; Smeets SJ; Tijssen M; Vosse SJ; Meijer CJ; Meijer GA; van de Wiel MA; Ylstra B
Genes Chromosomes Cancer; 2009 Mar; 48(3):250-60. PubMed ID: 19051311
[TBL] [Abstract][Full Text] [Related]
44. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
[TBL] [Abstract][Full Text] [Related]
45. Nuclear expression of YB-1 in diffuse large B-cell lymphoma: correlation with disease activity and patient outcome.
Xu W; Zhou L; Qin R; Tang H; Shen H
Eur J Haematol; 2009 Oct; 83(4):313-9. PubMed ID: 19500133
[TBL] [Abstract][Full Text] [Related]
46. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
[TBL] [Abstract][Full Text] [Related]
47. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
Costa LJ; Feldman AL; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Ansell SM
Br J Haematol; 2008 Jul; 142(3):404-12. PubMed ID: 18492096
[TBL] [Abstract][Full Text] [Related]
48. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
[TBL] [Abstract][Full Text] [Related]
49. Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma.
Fornecker LM; Muller L; Bertrand F; Paul N; Pichot A; Herbrecht R; Chenard MP; Mauvieux L; Vallat L; Bahram S; Cianférani S; Carapito R; Carapito C
Sci Rep; 2019 Jan; 9(1):895. PubMed ID: 30696890
[TBL] [Abstract][Full Text] [Related]
50. Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma.
Rydström K; Joost P; Ehinger M; Edén P; Jerkeman M; Cavallin-Ståhl E; Linderoth J
Leuk Lymphoma; 2012 Sep; 53(9):1764-8. PubMed ID: 22335531
[TBL] [Abstract][Full Text] [Related]
51. Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma.
Suzuki O; Abe M
Oncol Rep; 2008 Mar; 19(3):743-8. PubMed ID: 18288410
[TBL] [Abstract][Full Text] [Related]
52. FOXO4 expression is related to stem cell-like properties and resistance to treatment in diffuse large B-cell lymphoma.
Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
Oncotarget; 2017 Jan; 8(2):2466-2476. PubMed ID: 27911272
[TBL] [Abstract][Full Text] [Related]
53. Uncovering molecular abnormalities leading to the Warburg effect in primary refractory diffuse large B-cell lymphoma.
Soleja M; Mims M; Rivero G
Blood Cancer J; 2016 Dec; 6(12):e502. PubMed ID: 27911436
[No Abstract] [Full Text] [Related]
54. Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients.
Bram Ednersson S; Stenson M; Stern M; Enblad G; Fagman H; Nilsson-Ehle H; Hasselblom S; Andersson PO
Br J Haematol; 2018 Jun; 181(6):770-781. PubMed ID: 29767447
[TBL] [Abstract][Full Text] [Related]
55. Aberrant expression of CCR4 in diffuse large B-cell lymphoma, not otherwise specified.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Hiraoka N; Takayama A; Nishiwaki U; Masuda Y; Nishimura Y; Tsuji M; Hanafusa T
Leukemia; 2013 Dec; 27(12):2382-5. PubMed ID: 23612017
[No Abstract] [Full Text] [Related]
56. Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma.
Nowakowski GS; Vitolo U
Future Oncol; 2017 Apr; 13(10):859-862. PubMed ID: 28183193
[No Abstract] [Full Text] [Related]
57. [Angiomyofibroblastoma of the vulva: a rare but distinct entity. Case report and literature review].
Pellegrino M; Vadrucci S; Tinelli A
Pathologica; 2007 Dec; 99(6):438-9. PubMed ID: 18416337
[TBL] [Abstract][Full Text] [Related]
58. DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
Kizhakeyil A; Zaini NBM; Poh ZS; Wong BHS; Loh X; Ng AS; Low ZS; Prasannan P; Gong C; Tan MGK; Nagarajan C; Huang D; Lu PW; Lim JQ; Barrans S; Ong CK; Lim ST; Chng WJ; Follows G; Hodson DJ; Du MQ; Goh YT; Tan SH; Grigoropoulos NF; Verma NK
Mol Cancer; 2021 Oct; 20(1):134. PubMed ID: 34654425
[No Abstract] [Full Text] [Related]
59. A Large Tumour of the Mamma, Spontaneously Cured.
Greene AB
Med Exam (Phila); 1847 Feb; 3(26):117-120. PubMed ID: 38120473
[No Abstract] [Full Text] [Related]
60. Stromal gene signatures in large-B-cell lymphomas.
Lenz G; Wright G; Dave SS; Xiao W; Powell J; Zhao H; Xu W; Tan B; Goldschmidt N; Iqbal J; Vose J; Bast M; Fu K; Weisenburger DD; Greiner TC; Armitage JO; Kyle A; May L; Gascoyne RD; Connors JM; Troen G; Holte H; Kvaloy S; Dierickx D; Verhoef G; Delabie J; Smeland EB; Jares P; Martinez A; Lopez-Guillermo A; Montserrat E; Campo E; Braziel RM; Miller TP; Rimsza LM; Cook JR; Pohlman B; Sweetenham J; Tubbs RR; Fisher RI; Hartmann E; Rosenwald A; Ott G; Muller-Hermelink HK; Wrench D; Lister TA; Jaffe ES; Wilson WH; Chan WC; Staudt LM;
N Engl J Med; 2008 Nov; 359(22):2313-23. PubMed ID: 19038878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
